Lindsay A. Rosenwald

2013

In 2013, Lindsay A. Rosenwald earned a total compensation of $3.9M as Chairman, President and Chief Executive Officer at Fortress Biotech.

Compensation breakdown

Option Awards$76,800
Salary$980
Stock Awards$3,820,138
Total$3,897,918

Rosenwald received $3.8M in stock awards, accounting for 98% of the total pay in 2013.

Rosenwald also received $76.8K in option awards and $980 in salary.

Rankings

In 2013, Lindsay A. Rosenwald's compensation ranked 1,819th out of 12,286 executives tracked by ExecPay. In other words, Rosenwald earned more than 85.2% of executives.

ClassificationRankingPercentile
All
1,819
out of 12,286
85th
Division
Manufacturing
594
out of 4,612
87th
Major group
Chemicals And Allied Products
161
out of 1,466
89th
Industry group
Drugs
109
out of 1,160
91st
Industry
Pharmaceutical Preparations
93
out of 890
90th
Source: SEC filing on April 29, 2016.

Rosenwald's colleagues

We found two more compensation records of executives who worked with Lindsay A. Rosenwald at Fortress Biotech in 2013.

2013

George Avgerinos

Fortress Biotech

Senior Vice President, Biologics Operation

2013

Lucy Lu

Fortress Biotech

Chief Financial Officer

News

You may also like